Apotex`s Generic Glycopyrrolate Receives Approval in US

Apotex`s Generic Glycopyrrolate Receives Approval in US
FDA
07 Nov 2019
Share Share
Apotex`s Generic Pirfenidone Receives Tentative Approval in US

Apotex`s Generic Pirfenidone Receives Tentative Approval in US
FDA
30 Oct 2019
Share Share
Apotex`s Generic Glycopyrrolate Receives Approval in US

Apotex`s Generic Glycopyrrolate Receives Approval in US
FDA
29 Oct 2019
Share Share
Apotex`s Generic Sirolimus Receives Approval in US

Apotex`s Generic Sirolimus Receives Approval in US
FDA
25 Oct 2019
Share Share
Nevada Fines Drugmakers $17M for Failing to Comply With Drug Pricing Law

Nevada Fines Drugmakers $17M for Failing to Comply With Drug Pricing Law
Z.Brennan  RAPS
05 Oct 2019
Share Share
Apotex`s Generic Pirfenidone Receives Tentative Approval in US

Apotex`s Generic Pirfenidone Receives Tentative Approval in US
FDA
01 Oct 2019
Share Share
CVS suspends Zantac sales, as recalls widen over carcinogen fears

CVS suspends Zantac sales, as recalls widen over carcinogen fears
Andrew Dunn BIOPHARMADIVE
30 Sep 2019
Share Share
Health Canada says four more companies recalling versions of Zantac

Health Canada says four more companies recalling versions of Zantac
Manas Mishra REUTERS
27 Sep 2019
Share Share
J&J finds competitive edge with latest Erleada approval

J&J finds competitive edge with latest Erleada approval
Jacob Bell BIOPHARMADIVE
19 Sep 2019
Share Share
Apotex`s Generic Diphenhydramine HCL;Naproxen Sodium Receives Approval in US

Apotex`s Generic Diphenhydramine HCL;Naproxen Sodium Receives Approval in US
FDA
27 Aug 2019
Share Share

All Pharma News All Pharma News

TOP 10 NEWS OF THE DAY
TOP 10 NEWS
OF THE DAY
NEWS LIBRARY
NEWS
LIBRARY
COMPLIANCE ALERTS
COMPLIANCE
ALERTS
RECENT APPROVALS
RECENT
APPROVALS
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty

PharmaCompass